Tuesday, June 26 • 9:30am - 10:30am
#220: Brexit: Practical Real-World Solution Planning

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Workshop
Level: Basic

This Engage and Exchange workshop will be a discussion on impacts of Brexit on regulatory issues facing pharmaceutical sector, areas of work that will be affected and when to take action. The participants will be exchanging best practices and finding practical solutions to the upcoming regulatory challenges.

Learning Objectives

Discuss the uncertainties around Brexit and the real-world regulatory challenges of Brexit; Describe and come up with practical solutions to the real-world scenarios that the UK withdrawal from EU will create; Discuss how to strategically plan for and prepare license transfers, variations, clinical trials and supply chains affected by Brexit.


Parastoo Karoon


MHRA Perspective
Mick Foy

avatar for Mick Foy

Mick Foy

Head of Pharmacovigilance Strategy, Vigilance Intelligence, and Research Group, Medicines and Healthcare Products Regulatory Agency (MHRA)
Mick Foy is Head of Pharmacovigilance Strategy at the MHRA. Among is responsibilities is the running of the UK ADR reporting system and signal detection activities. Mick is also leads the MHRA's work with WHO and the Bill and Melinda Gates Foundation on capacity building in low and... Read More →

Parastoo Karoon

Principal Consultant, PAREXEL International
Dr Parastoo Karoon - PhD, Principal Consultant PAREXEL, provides advice on drug development & submission strategies, interactions with Regulatory Authorities & regulatory issues. She performs gap analysis, due diligence, scientific advice, MAA & variation. With 12 years of experience... Read More →

Tuesday June 26, 2018 9:30am - 10:30am
E and E Exhibit Hall Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA